VCYT

25.4801.76%
MA

Marc A. Stapley

CEO & Director

Mr. Marc A. Stapley serves as Chief Executive Officer at Veracyte, Inc. since June 1, 2021 and serves as its Director since June 08, 2021. He served as the Chief Executive Officer of Helix OpCo, LLC from April 2019 to May 2021. He served as Independent Director at Immunis.AI until 2022. He has been Director at Pci Media Inc since May 2019. He served as an Executive Vice President of Strategy and Corporate Development at Illumina, Inc. from 2017 to January 1, 2019 and served as its Executive Vice President from October 2017 to January 2019 and Chief Administrative Officer from December 2015 to October 2017. Mr. Stapley served as the Chief Financial Officer of Illumina, Inc. from January 2012 to January 6, 2017 and served as its Principal Accounting Officer until January 1, 2013. He served as its Senior Vice President since 2012. From 2009 to 2012, Mr. Stapley served as Senior Vice President of finance at Pfizer Inc. and was responsible for global financial processes and systems, leading integration efforts in both the Wyeth and King Pharmaceutical acquisitions and providing oversight to its largest technology investment program. Prior to Pfizer, he served in a variety of senior finance roles at Alcatel-Lucent, including Americas Chief Financial Officer. He worked as a Finance Director and Controller for several groups at Cadence Design Systems. He began his career as an Auditor at Coopers & Lybrand. Mr. Stapley serves as member of the board of directors of Helix since April 2019. He has been Independent Director of Glaukos Corporation since July 2014. He holds a BSc (Honors) in Mathematics from The University of Reading (England) and is a member of the Institute of Chartered Accountants in England and Wales.

Positions